Pancreatic Cancer Research

ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed

Xingcheng Xiong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1808-0451; OpenAlex author ID A5016109674. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers

Papers 4

  1. microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3. Co-author DOI 10.1007/s10565-021-09597-x↗
  2. Identifying a novel IRF3/circUHRF1/miR-1306-5p/ARL4C axis in pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1080/15384101.2021.2020450↗
  3. Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer. Co-author DOI 10.1186/s12935-021-01812-3↗
  4. LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. Co-author DOI 10.1002/jcp.28209↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Tao · 4 shared papers, 2019–2022 · strength 0.61
  2. Jian Hua Chang · 3 shared papers, 2021–2022 · strength 0.49
  3. Hanjun Li · 2 shared papers, 2021–2022 · strength 0.32
  4. Weimin Hu · 1 shared paper, 2022 · strength 0.17
  5. Pei Mei · 1 shared paper, 2022 · strength 0.17
  6. Zhilin Zhou · 1 shared paper, 2022 · strength 0.16
  7. Wei Liu · 1 shared paper, 2022 · strength 0.16
  8. Weixing Wang · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.